Read articles from North America

July 06, 2026 by regulatorwatch.com

The FDA’s flavour policy increasingly appears disconnected from how adult smokers actually switch away from cigarettes. Flavours are not just a youth issue — for many adults, they help make vaping a workable alternative to combustible tobacco. If regulation removes the products people find acceptable, it may weaken harm reduction while leaving cigarettes widely available. Public health policy should reflect real-world behaviour, not assumptions that ignore why switching succeeds.

July 06, 2026 by regulatorwatch.com

The FDA’s flavour policy increasingly appears disconnected from how adult smokers actually switch away from cigarettes. Flavours are not just a youth issue — for many adults, they help make vaping a workable alternative to combustible tobacco. If regulation removes the products people find acceptable, it may weaken harm reduction while leaving cigarettes widely available. Public health policy should reflect real-world behaviour, not assumptions that ignore why switching succeeds.

July 03, 2026 by clearingtheair.eu

Survey findings suggest that many online nicotine pouch customers are using them as part of a move away from smoking or vaping. Nearly half reportedly tried pouches to quit, showing that smoke-free alternatives can play a role in real-world behaviour change. Policy should recognise why adults choose these products rather than assuming all use is the same. Harm reduction works best when regulation reflects consumer motivations, relative risk and practical routes away from more harmful products.

July 03, 2026 by gfn.tv

Nicotine addiction should be understood with nuance, not moral panic. Dependence is real, but it should not be confused with the harms caused by burning tobacco. For people who smoke, moving to lower-risk nicotine products can reduce exposure to the toxicants responsible for most smoking-related disease. Better policy starts by separating addiction, risk and harm — and by helping people make safer choices.

July 03, 2026 by dailycaller.com

The FDA’s ruling on nicotine pouches is a major step towards honest relative-risk communication. By recognising that authorised smoke-free products can present lower risks than cigarettes, regulators are acknowledging what tobacco harm reduction has long argued: combustion is the central danger. Adult smokers need clear, accurate information about alternatives that may help them move away from cigarettes. Public health policy should make safer choices easier to understand, not harder to access.

July 03, 2026 by reason.org

Southern California’s total tobacco bans raise serious questions about whether prohibition is improving public health or simply shifting behaviour elsewhere. When legal access is removed, consumers may turn to neighbouring markets, illicit sellers or more harmful products that remain easier to obtain. Policies aimed at reducing harm should be judged by real-world outcomes, not symbolic restrictions. Effective regulation should protect young people while preserving realistic pathways away from combustible tobacco.

July 02, 2026 by realclearscience.com

The FDA’s authorisation of modified risk claims for ZYN nicotine pouches marks a public health win for evidence-based risk communication. It recognises a simple but often ignored fact: smoke-free nicotine products do not carry the same risks as combustible cigarettes. For adult smokers, clear information about lower-risk alternatives can support better decisions and more realistic routes away from smoking. Public health should follow the science, not blur all nicotine products into the same category.

July 01, 2026 by reuters.com

The FDA’s decision to allow ZYN nicotine pouches to be marketed as less harmful than cigarettes is a major moment for relative-risk communication. The agency has authorised claims for 20 ZYN products, recognising that switching completely from smoking to these smoke-free alternatives can reduce the risk of several serious diseases. For adult smokers, clear information matters: not all nicotine products carry the same level of harm. Public health should make evidence-based switching messages easier to understand, not harder to hear.

July 01, 2026 by fda.gov

The FDA’s authorisation of modified risk claims for 20 ZYN nicotine pouch products marks an important step for evidence-based nicotine communication. Adults who smoke should be able to receive clear information that switching completely from cigarettes to authorised smoke-free products can reduce specific disease risks. The decision recognises that not all nicotine products carry the same harm, and that accurate relative-risk messaging can support better choices. Public health should make lower-risk information visible, not harder to say.

June 30, 2026 by regulatorwatch.com

The US vape court battles show how contested the future of harm reduction has become. While cigarettes remain widely available, regulated vaping products face years of legal uncertainty, approval delays and enforcement disputes. For adult smokers, that means fewer reliable routes away from combustible tobacco. Public health policy should protect young people without keeping lower-risk alternatives trapped in a regulatory battleground.